Tradestie Institutional Equity Comparison Engine
RBOT.WS vs EW โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EW Overall Edge
EW Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edwards Lifesciences Corp (EW) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RBOT.WS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus EW at 30.1x Forward P/E and 28.8% operating margin (+10.5% YoY). In options structure, RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EW sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
EW
RBOT.WS N/M vs EW 30.1x Fwd P/E
Growth & Margin Winner
EW
Op Margin N/A vs 28.8% ยท YoY N/A vs +10.5%
Momentum & Technical Winner
EW
1Y -67.2% vs +18.4% ยท 52W Pos 0% vs 82%
Options & Structure Winner
EW
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (100th %ile IV)
RBOT.WS
NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap
N/A
1M Return
-67.2%
1Y Return
-67.2%
Forward P/E
N/M
Unified AI Score
50.1 / 100
HOLD
Tech 40.0
Fund 46.0
Flow 50.0
Mom 50.0
EW
NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$101.85
-1.95% 1D
Market Cap
$59.7B
1M Return
+13.05%
1Y Return
+18.4%
Forward P/E
30.1x
Unified AI Score
40.0 / 100
SELL
Tech 24.0
Fund 43.0
Flow 55.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RBOT.WS -67.2%
EW +18.4%
Spread: +66.45 pp (EW Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RBOT.WS TTM Op. Margin: N/A
EW TTM Op. Margin: 28.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBOT.WS vs EW. Trailing 12-month operating profitability (RBOT.WS N/A vs EW 28.8%) and valuation multiples (RBOT.WS N/M vs EW 30.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RBOT.WS | EW | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $59.7B | Larger Scale | EW |
| Trailing P/E Ratio Valuation | N/M | 60.4x | Lower Multiple | EW |
| Forward P/E Ratio Valuation | N/M | 30.1x | Lower Multiple | EW |
| Revenue Growth (YoY) Growth | N/A | +10.5% | Higher Growth | EW |
| Operating Margin (TTM) Profitability | N/A | 28.8% | Higher Margin | EW |
| Net Profit Margin Profitability | N/A | 15.3% | Higher Margin | EW |
| Return on Equity (ROE) Capital Efficiency | N/A | 9.3% | Higher ROE | EW |
| 52-Week Range Position Momentum | 0% ($0โ$0) | 82% ($75โ$108) | Stronger Trend | EW |
| Beta / 30D Volatility Risk Regime | N/A | 0.43ฮฒ ยท 27% Vol | Lower Realized Risk | EW |
| Unified Institutional Score Composite Signal | 50.1 / 100 (HOLD) | 40.0 / 100 (SELL) | Higher Composite | RBOT.WS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RBOT.WS vs EW Buy Guide
RBOT.WS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
EW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RBOT.WS nor EW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.